Julie Adams

Julie L. Adams, MD, MPH is Executive Medical Director and Head of Precision Medicine for Neuroscience at AbbVie, where she leads a multidisciplinary team responsible for precision medicine strategy, clinical translation, and biomarker development across a broad neuroscience portfolio. With more than two decades of experience spanning clinical development, psychiatry, neurodegeneration, rare diseases, and translational medicine, Dr. Adams has guided global programs from first-in-human studies through registration and lifecycle management. Her leadership has contributed to multiple successful regulatory approvals and label expansions, including Vraylar and other neuroscience assets. Prior to AbbVie, Dr. Adams held senior development leadership roles at Otsuka and PPD and served on the faculty of Duke University Medical Center. An active contributor to the scientific community, Dr. Adams serves in leadership roles with several international neuroscience and clinical research organizations. Dr. Adams holds an MD from Loma Linda University, an MPH in Epidemiology from the University of North Carolina, and is board certified in Psychiatry and Neurology.